Product Information
ZYPREXA 20 MG TABLET is a brand product labeled by H2-Pharma LLC, priced at $49.9107 per EA under NDC 61269063530. Its NADAC has been published 97 times since Oct 16, 2024.
FDA first approved this application on Sep 30, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
H2-Pharma LLCNDC
61269063530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OLANZAPINEApproval Type
New Drug (NDA)
FDA Application
NDA020592FDA Approved
9/30/1996
TE Code
AB
On Market Since
3/1/2001
Pharmacological Classes
Price Statistics
The NADAC for ZYPREXA 20 MG TABLET has been published 97 times since Oct 16, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.9107 per EA |
|---|---|
| All-time high | $50.0557 (Jul 16, 2025) |
| All-time low | $49.7226 (Apr 22, 2026) |
| 52-week high | $50.0337 |
| 52-week low | $49.7226 |
| Median price | $49.8671 |
| Average price | $49.8749 |
| Largest weekly change | +0.5% (May 21, 2025) |
| Weeks tracked | 97 |
| Tracking since | Oct 16, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZYPREXA 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZYPREXA 20 MG TABLET, manufactured by H2-Pharma LLC, is $49.9107 per EA (NDC 61269063530), effective Aug 19, 2026.
How has the price of ZYPREXA 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZYPREXA 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 97 weekly CMS publications since Oct 16, 2024.
What are the highest and lowest recorded NADAC prices for ZYPREXA 20 MG TABLET?
Since Oct 16, 2024, the NADAC for ZYPREXA 20 MG TABLET has ranged from a low of $49.7226 (Apr 22, 2026) to a high of $50.0557 (Jul 16, 2025), with a median of $49.8671 per EA.
Are there cheaper alternatives to ZYPREXA 20 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLANZAPINE 20 MG TABLET, is $0.1432 per EA — about 99% below ZYPREXA 20 MG TABLET.
Who manufactures ZYPREXA 20 MG TABLET?
ZYPREXA 20 MG TABLET (NDC 61269063530) is labeled by H2-Pharma LLC, and CMS classifies it as a brand product.